Cubicin recall: Particulate Matter
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.…
Why was Cubicin recalled?
Presence of Particulate Matter: Identified as Glass Particles
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 934778, Exp. Date Jun 2022
- Product
- Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.…
- Recalling firm
- MERCK SHARP & DOHME CORP
- Quantity
- 76,163 vials
- Distribution
- Nationwide within the United States
- Recall date
- November 10, 2021
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)